Market Cap 1.65B
Revenue (ttm) 276.26M
Net Income (ttm) 16.52M
EPS (ttm) N/A
PE Ratio 104.95
Forward PE 72.00
Profit Margin 5.98%
Debt to Equity Ratio 0.00
Volume 604,400
Avg Vol 505,100
Day's Range N/A - N/A
Shares Out 50.76M
Stochastic %K 33%
Beta 1.22
Analysts Strong Sell
Price Target $55.43

Company Profile

Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies and specialty biologic products for sports medicine and severe burn care markets in North America. The company markets autologous cell therapy products comprising MACI, an autologous cultured chondrocytes on porcine collagen membrane for the repair of symptomatic, and single or multiple full-thickness cartilage defects of the knee; Epicel, a...

Industry: Biotechnology
Sector: Healthcare
Phone: 617 588 5555
Fax: 617 588 5554
Address:
64 Sidney Street, Cambridge, United States
OfficialStocktwitsUser
OfficialStocktwitsUser Mar. 13 at 5:59 PM
$VCEL RSI: 15.89, MACD: -1.1844 Vol: 2.17, MA20: 35.49, MA50: 36.41 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
copperhat
copperhat Mar. 13 at 3:28 PM
$VCEL wtf is wrong with this? Hardly threatened by AI.
1 · Reply
Pro_From_Dover
Pro_From_Dover Mar. 12 at 4:41 PM
$VCEL WTF!!?? Into the 31’s again? Come on already
0 · Reply
copperhat
copperhat Mar. 12 at 12:35 PM
$VCEL a bit unsettling to see a price of $0.00
0 · Reply
copperhat
copperhat Mar. 10 at 2:12 PM
$VCEL will this ever recover?
1 · Reply
Twister8
Twister8 Mar. 6 at 4:03 PM
$VCEL Nick’s song and dance is getting really old…
0 · Reply
Twister8
Twister8 Mar. 6 at 4:00 PM
$VCEL yep
0 · Reply
Groyper69
Groyper69 Mar. 6 at 6:21 AM
$VCEL FDA approval and good earnings report and we get a selloff????!
2 · Reply
Pro_From_Dover
Pro_From_Dover Mar. 5 at 4:21 PM
$VCEL punishing. simply punishing. lame company bringing up the rear.
0 · Reply
cush6
cush6 Mar. 4 at 1:42 PM
$VCEL Vericel Gets FDA Approval for Massachusetts Therapy Manufacturing Facility 08:32 AM EST, 03/04/2026 (MT Newswires) -- Vericel (VCEL) said Wednesday it has received approval for the commercial manufacturing of autologous cultured chondrocytes on porcine collagen membrane, or MACI, as its Massachusetts facility from the US Food and Drug Administration. The approval allows Vericel to start commercial production of the knee cartilage repair product at the facility in Burlington in Q2, allowing it to meet increasing demand, the company said.
1 · Reply
Latest News on VCEL
Vericel Corporation (VCEL) Q4 2025 Earnings Call Transcript

Feb 26, 2026, 12:58 PM EST - 17 days ago

Vericel Corporation (VCEL) Q4 2025 Earnings Call Transcript


Vericel Corporation (VCEL) Q3 2025 Earnings Call Transcript

Nov 6, 2025, 2:46 PM EST - 4 months ago

Vericel Corporation (VCEL) Q3 2025 Earnings Call Transcript


Vericel Reports Third Quarter 2025 Financial Results

Nov 6, 2025, 7:55 AM EST - 4 months ago

Vericel Reports Third Quarter 2025 Financial Results


Vericel Corporation (VCEL) Q2 2025 Earnings Call Transcript

Jul 31, 2025, 3:10 PM EDT - 8 months ago

Vericel Corporation (VCEL) Q2 2025 Earnings Call Transcript


Vericel Reports Second Quarter 2025 Financial Results

Jul 31, 2025, 8:08 AM EDT - 8 months ago

Vericel Reports Second Quarter 2025 Financial Results


Vericel Corporation: Moving From Sell To Neutral

Jun 12, 2025, 10:23 AM EDT - 9 months ago

Vericel Corporation: Moving From Sell To Neutral


Vericel: Scalable Growth With Strong Margins

Mar 5, 2025, 11:56 PM EST - 1 year ago

Vericel: Scalable Growth With Strong Margins


Vericel to Present at Multiple Upcoming Investor Conferences

Mar 4, 2025, 8:30 AM EST - 1 year ago

Vericel to Present at Multiple Upcoming Investor Conferences


Vericel Corporation: Hard To Justify Current Valuation

Dec 19, 2024, 12:50 PM EST - 1 year ago

Vericel Corporation: Hard To Justify Current Valuation


Vericel Reports Third Quarter 2024 Financial Results

Nov 7, 2024, 7:55 AM EST - 1 year ago

Vericel Reports Third Quarter 2024 Financial Results


Vericel Corporation (VCEL) Q2 2024 Earnings Call Transcript

Aug 1, 2024, 3:58 PM EDT - 1 year ago

Vericel Corporation (VCEL) Q2 2024 Earnings Call Transcript


Vericel Reports Second Quarter 2024 Financial Results

Aug 1, 2024, 7:55 AM EDT - 1 year ago

Vericel Reports Second Quarter 2024 Financial Results


Vericel Corporation (VCEL) Q1 2024 Earnings Call Transcript

May 8, 2024, 2:36 PM EDT - 2 years ago

Vericel Corporation (VCEL) Q1 2024 Earnings Call Transcript


Vericel Corporation (VCEL) Q4 2023 Earnings Call Transcript

Feb 29, 2024, 11:39 AM EST - 2 years ago

Vericel Corporation (VCEL) Q4 2023 Earnings Call Transcript


OfficialStocktwitsUser
OfficialStocktwitsUser Mar. 13 at 5:59 PM
$VCEL RSI: 15.89, MACD: -1.1844 Vol: 2.17, MA20: 35.49, MA50: 36.41 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
copperhat
copperhat Mar. 13 at 3:28 PM
$VCEL wtf is wrong with this? Hardly threatened by AI.
1 · Reply
Pro_From_Dover
Pro_From_Dover Mar. 12 at 4:41 PM
$VCEL WTF!!?? Into the 31’s again? Come on already
0 · Reply
copperhat
copperhat Mar. 12 at 12:35 PM
$VCEL a bit unsettling to see a price of $0.00
0 · Reply
copperhat
copperhat Mar. 10 at 2:12 PM
$VCEL will this ever recover?
1 · Reply
Twister8
Twister8 Mar. 6 at 4:03 PM
$VCEL Nick’s song and dance is getting really old…
0 · Reply
Twister8
Twister8 Mar. 6 at 4:00 PM
$VCEL yep
0 · Reply
Groyper69
Groyper69 Mar. 6 at 6:21 AM
$VCEL FDA approval and good earnings report and we get a selloff????!
2 · Reply
Pro_From_Dover
Pro_From_Dover Mar. 5 at 4:21 PM
$VCEL punishing. simply punishing. lame company bringing up the rear.
0 · Reply
cush6
cush6 Mar. 4 at 1:42 PM
$VCEL Vericel Gets FDA Approval for Massachusetts Therapy Manufacturing Facility 08:32 AM EST, 03/04/2026 (MT Newswires) -- Vericel (VCEL) said Wednesday it has received approval for the commercial manufacturing of autologous cultured chondrocytes on porcine collagen membrane, or MACI, as its Massachusetts facility from the US Food and Drug Administration. The approval allows Vericel to start commercial production of the knee cartilage repair product at the facility in Burlington in Q2, allowing it to meet increasing demand, the company said.
1 · Reply
StockNews_Live
StockNews_Live Mar. 4 at 1:01 PM
$VCEL Vericel Corporation announced that the U.S. Food and Drug Administration (FDA) has granted approval for MACI commercial manufacturing at its state-of-the-art cell therapy manufacturing facility in Bur…
0 · Reply
TheTradeXchange
TheTradeXchange Mar. 4 at 1:00 PM
$VCEL - Vericel Announces FDA Approval of New State-of-the-Art Advanced Therapy Manufacturing Facility
0 · Reply
StockNews_Live
StockNews_Live Mar. 4 at 1:00 PM
$VCEL Vericel Corporation announced that the U.S. Food and Drug Administration (FDA) has granted approval for MACI commercial manufacturing at its state-of-the-art cell therapy manufacturing facility in Bur…
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Mar. 3 at 7:37 PM
$VCEL RSI: 45.75, MACD: -0.2341 Vol: 1.32, MA20: 36.43, MA50: 37.01 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
Pro_From_Dover
Pro_From_Dover Mar. 2 at 3:04 PM
$VCEL fricken awesome. first the punishment for earnings, and now punishment for a war no one wants except the braggard in DC. jeez... what else can go wrong.
0 · Reply
JohnPDaly
JohnPDaly Mar. 1 at 7:10 PM
$MDWD from the $VCEL ER: For Burn Care, we are maintaining our run rate approach to guidance, with revenue of approximately $9-$10 million per quarter, recognizing that revenue can vary on a quarterly basis. For the full year, this points to approximately $36-$40 million of total Burn Care revenue. Of note, we are not assuming any additional NexoBrid revenue in our initial guidance related to a potential BARDA award, although there is a reasonable possibility for incremental NexoBrid BARDA revenue during the year. For the Q1, we are on track to exceed 20% total company revenue growth as we are off to a very strong start to the year for both franchises. MACI's Q4 momentum has continued into this year, with MACI performance trending toward higher Q1 growth than in recent years, and Burn Care performance trends have also been strong to start the year.
0 · Reply
Pro_From_Dover
Pro_From_Dover Feb. 27 at 3:04 PM
$VCEL jeez loueez folks. a good report, one upgrade on PPS target, one downgrade, and a punishing 6%+ gutting today. management MUST go... this is pathetic.
0 · Reply
enalpa
enalpa Feb. 26 at 5:55 PM
$VCEL twister8 has appeared to have gone short
2 · Reply
Twister8
Twister8 Feb. 26 at 5:41 PM
$VCEL why does every earnings call feel like MACI was just introduced to the market a year or two ago?
0 · Reply
Twister8
Twister8 Feb. 26 at 4:41 PM
$VCEL the burn franchise is small unpredictable niche at best.
0 · Reply
Twister8
Twister8 Feb. 26 at 4:40 PM
$VCEL nexobrid is a dud.
1 · Reply
Twister8
Twister8 Feb. 26 at 4:37 PM
$VCEL with no OTS option, maci is most likely maxed out on penetration unless a new indication emerges.
0 · Reply